Medicare Enrolled
Dr. Gary Pepper, M.D.
Endocrinology · Jupiter, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pepper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pepper? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pepper
Dr. Gary Pepper is an endocrinology in Jupiter, FL, with 19 years in practice. Based on federal Medicare data, Dr. Pepper performed 8,259 Medicare services across 5,558 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pepper received a total of $34,623 from 65 pharmaceutical and/or device companies across 754 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pepper is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 9% volume in FL$ $34,623 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,259
Medicare services
Top 9% in FL for endocrinology
5,558
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~435 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) | 891 | $8 | $10 |
| Office visit, established patient (30-39 min) | 856 | $88 | $205 |
| Thyroid stimulating hormone (TSH) test | 668 | $16 | $48 |
| Thyroxine (thyroid chemical), total | 581 | $7 | $25 |
| Thyroid hormone evaluation | 578 | $6 | $20 |
| Thyroid hormone, t3 measurement, total | 479 | $14 | $41 |
| Chronic care management, first 20 min/month | 452 | $44 | $100 |
| Kidney function blood test panel | 449 | $8 | $100 |
| Lipid panel (cholesterol and triglycerides) | 393 | $13 | $38 |
| Blood glucose (sugar) measurement using reagent strip | 393 | $5 | $6 |
| Comprehensive metabolic blood panel | 337 | $10 | $60 |
| Glycated protein level | 312 | $16 | $43 |
| Creatinine test (kidney function) | 277 | $5 | $15 |
| Urine microalbumin (protein) analysis | 273 | $6 | $17 |
| Hemoglobin A1c test (diabetes monitoring) | 106 | $10 | $28 |
| Diabetes outpatient self-management training services, individual, per 30 minutes | 105 | $43 | $100 |
| Thyroglobulin (thyroid protein) antibody measurement | 99 | $16 | $60 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 95 | $27 | $86 |
| Free thyroxine (T4) test | 88 | $9 | $30 |
| Parathyroid hormone level test | 85 | $40 | $118 |
| Microsomal antibodies (autoantibody) measurement | 80 | $14 | $50 |
| Ultrasound scan of head and neck soft tissue | 77 | $88 | $223 |
| New patient office visit (45-59 min) | 76 | $110 | $318 |
| Remote patient monitoring management, 20 min/month | 71 | $37 | $120 |
| Complete blood count (CBC) with differential | 68 | $8 | $50 |
| Vitamin D level test | 66 | $29 | $80 |
| Office visit, established patient (20-29 min) | 45 | $63 | $136 |
| Chronic care management, additional 20 min/month | 41 | $36 | $80 |
| Adrenocorticotropic hormone (acth) level | 37 | $38 | $111 |
| Cortisol (hormone) measurement, total | 36 | $16 | $47 |
| Remote patient monitoring device, 30 days | 36 | $38 | $110 |
| Testosterone (hormone) level, total | 29 | $25 | $74 |
| Thyroglobulin (thyroid related hormone) level | 21 | $16 | $46 |
| Thyroid stimulating immune globulins (thyroid related protein) level | 16 | $50 | $120 |
| Prolactin (milk producing hormone) level | 15 | $19 | $56 |
| PSA test (prostate cancer screening) | 14 | $18 | $53 |
| Psa (prostate specific antigen) measurement, free | 14 | $18 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$34,623
Total received (2018-2024)
Avg $4,946/year across 7 years
Top 12% in FL for endocrinology
65
Companies
754
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,840 (40.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,983 (31.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,800 (28.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,925
2023$5,397
2022$4,590
2021$4,417
2020$10,793
2019$3,767
2018$2,734
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Acella Pharmaceuticals, LLC
$11,064
ABBVIE INC.
$9,800
Novo Nordisk Inc
$1,950
SANOFI-AVENTIS U.S. LLC
$1,295
Tosoh Bioscience, Inc.
$1,105
AstraZeneca Pharmaceuticals LP
$872
Lilly USA, LLC
$827
Endo Pharmaceuticals Inc.
$703
Amgen Inc.
$424
Insulet Corporation
$418
Amarin Pharma Inc.
$407
Valeritas, Inc.
$375
Mannkind Corporation
$359
Bayer Healthcare Pharmaceuticals Inc.
$318
MannKind Corporation
$313
Radius Health, Inc.
$310
Abbott Laboratories
$290
Tandem Diabetes Care, Inc.
$280
Xeris Pharmaceuticals, Inc.
$271
Boehringer Ingelheim Pharmaceuticals, Inc.
$239
Amneal Pharmaceuticals LLC
$223
Ipsen Biopharmaceuticals, Inc
$215
Merck Sharp & Dohme Corporation
$174
Bayer HealthCare Pharmaceuticals Inc.
$171
AbbVie, Inc.
$168
AbbVie Inc.
$155
RECORDATI_RARE_DISEASES_INC.
$135
Janssen Pharmaceuticals, Inc
$113
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$99
Becton, Dickinson and Company
$97
Antares Pharma, Inc.
$95
Shire North American Group Inc
$94
LifeScan, Inc.
$94
Medtronic MiniMed, Inc.
$92
Aytu BioScience, Inc
$77
PFIZER INC.
$68
Alexion Pharmaceuticals, Inc.
$66
Alfasigma USA, Inc.
$62
Zealand Pharma US, Inc.
$53
VIVUS, Inc.
$52
LIFESCAN, INC.
$49
Esperion Therapeutics, Inc.
$48
Medtronic, Inc.
$46
Gemini Laboratories, LLC
$44
Corcept Therapeutics
$39
DEXCOM, INC.
$36
Strongbridge US INC.
$35
EUSA Pharma (US) LLC
$34
Amryt Pharma Holdings Ltd
$34
Horizon Therapeutics plc
$33
Quidel Corporation
$32
Ascendis Pharma Inc
$28
Eisai Inc.
$26
Orexigen Therapeutics, Inc.
$26
Companion Medical, Inc.
$25
Novartis Pharmaceuticals Corporation
$20
Organogenesis Inc.
$20
Alvogen Inc
$18
Kyowa Kirin, Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Azurity Pharmaceuticals, Inc.
$16
Dexcom, Inc.
$16
IBSA Pharma Inc.
$15
Cardiovascular Systems Inc.
$12
Currax Pharmaceuticals LLC
$12
Top 3 companies account for 65.9% of total payments
Associated products mentioned in payments ›
25-OH Vitamin D ST AIA-Pack · AFREZZA · AIA-PACK Calibrator Set · ARMOUR THYROID · AVEED · Adthyza · Androgel · Apligraf · BAQSIMI · BD NANO · BD Nano · C-PEPTIDE · CONTRAVE · CYCLOSET · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HAWKONE · HUMULIN · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LOKELMA · Lenvima · MACRILEN · MOUNJARO · MYCAPSSA · Macrilen · Minimed 670G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid · NP Thyroid 60 · Natesto · ONETOUCH VERIO REFLECT · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · Peripheral Orbital Atherectomy System · Prolia · QSYMIA · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STRENSIQ · SYNTHROID · Saxenda · Somatuline Depot · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TESTOPEL · TOUJEO · TRULICITY · TU · TZIELD · Tirosint · Tresiba · Triage · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (40%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $419 per 100 Medicare services performed
Geographic Context
Endocrinologys within 10 mi
30
Per 100K population
2.0
County median income
$81,115
Nearest hospital
JUPITER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Pepper is a clinical cardiology specialist, with above-average Medicare volume (top 9% in FL), and high industry engagement (mixed engagement, top 12%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Pepper experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Pepper performed 891 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pepper receive payments from pharmaceutical companies?
Yes. Dr. Pepper received a total of $34,623 from 65 companies across 754 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pepper's costs compare to other endocrinologys in Jupiter?
Dr. Pepper's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pepper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologys in Jupiter
Browse endocrinologys in Jupiter ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologys in FL
Endocrinologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologys in FL
Which FL endocrinologys receive the most from drug and device companies.
By company
Acella Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from Acella Pharmaceuticals, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology